| Business Summary | | Cryomedical
Sciences,
Inc.
is
engaged
in
the
research,
development,
manufacture
and
marketing
of
products
for
use
in
the
cryoablation
and
preservation
of
cells,
tissues
and
organs
in
low
temperature
environments.
The
Company
has
developed
cryosurgical
systems
called
the
CMS
AccuProbe
System,
the
CMS
Blizzard
Series
and
the
Cryo-Lite
Series.
The
AccuProbe,
the
Blizzard
and
the
Cryo-Lite
are
cryosurgical
devices
designed
to
freeze
and
destroy
diseased
tissue.
They
are
particularly
applicable
where
diseased
tissue
cannot
be
removed
surgically
or
where
surgery
is
likely
to
have
extensive
adverse
side
effects. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cryomedical
Sciences
is
engaged
in
researching,
developing,
manufacturing
and
marketing
products
for
use
in
the
field
of
low-temperature
medical
applications
worldwide.
For
the
six
months
ended
6/30/01,
net
revenues
rose
25%
to
$789
thousand.
Net
loss
totalled
$2.4
million,
up
from
$1
million.
Revenues
reflect
an
increase
in
the
number
of
CMS
AccuProbe
Systems
and
accessories
sold.
Higher
loss
reflects
an
increase
in
personnel-related
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Andrew Greuling Pres,
CEO, Director | -- | Howard Breslow, 60 Director
and Sec. | -- | John Baust, Ph.D., 57 Sr.
VP and CSO | $106K | Marie Molnar-Hammond VP
of Sales and Marketing | -- | Dollar amounts are as of 26-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|